Evidence map›Paper›PMID 24687333›Full record

ReviewALTEX2014

Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities.

Lena Smirnova, Helena T Hogberg, Marcel Leist, Thomas Hartung

Abstract readReview
In one paragraph

Review in ALTEX, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Combined Modeling Approaches for Assessing Sodium-Iodide Symporter Inhibition.Journal of chemical information and modeling · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Organoid intelligence for developmental neurotoxicity testing.Frontiers in cellular neuroscience · 2024
    Article
  19. Article
  20. Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lena SmirnovaCenters for Alternatives to Animal Testing (CAAT) at Johns Hopkins Bloomberg School of Public Health, USA.
Helena T Hogberg
Marcel Leist
Thomas Hartung

Funding

Mapping the Human Toxome by Systems ToxicologyR01ES020750 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI HARTUNG, THOMAS · 2011 to 2015
$6.0M
A 3D Model of Human Brain Development for Studying Gene/Environment InteractionsU18TR000547 · NCATS · JOHNS HOPKINS UNIVERSITY · PI HARTUNG, THOMAS · 2012 to 2013
$865k
FDA HHS U01 FD004230FDA HHS U01FD004230NCATS NIH HHS U18 TR000547NIEHS NIH HHS R01 ES020750NIEHS NIH HHS R01ES020750
6 · The paper itself

Abstract

In recent years neurodevelopmental problems in children have increased at a rate that suggests lifestyle factors and chemical exposures as likely contributors. When environmental chemicals contribute to neurodevelopmental disorders developmental neurotoxicity (DNT) becomes an enormous concern. But how can it be tackled? Current animal test- based guidelines are prohibitively expensive, at $ 1.4 million per substance, while their predictivity for human health effects may be limited, and mechanistic data that would help species extrapolation are not available. A broader screening for substances of concern requires a reliable testing strategy, applicable to larger numbers of substances, and sufficiently predictive to warrant further testing. This review discusses the evidence for possible contributions of environmental chemicals to DNT, limitations of the current test paradigm, emerging concepts and technologies pertinent to in vitro DNT testing and assay evaluation, as well as the prospect of a paradigm shift based on 21st century technologies.

Indexed as

AnimalsAnimal Testing AlternativesHazardous SubstancesHumansNeuronsNeurotoxicity SyndromesNeurotoxinsToxicity TestsHazardous SubstancesNeurotoxins

Identifiers

PMID24687333
PMCPMC4778747

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.